Clinical Features and Prognostic Factors for Dermatomyositis-Associated Interstitial Lung Diseases with Anti-MDA5 Antibody

被引：0
|
作者：
Fujisawa, T. [1 ]
Hozumi, H. [1 ]
Yasui, H. [1 ]
Suzuki, Y. [1 ]
Karayama, M. [1 ]
Furuhashi, K. [1 ]
Enomoto, N. [1 ]
Nakamura, Y. [1 ]
Inui, N. [2 ]
Suda, T. [1 ]
机构：
[1] Hamamatsu Univ Sch Med, Dept Internal Med, Div 2, Hamamatsu, Shizuoka, Japan
[2] Hamamatsu Univ Sch Med, Deparmtne Clin Pharmacol & Therapeut, Hamamatsu, Shizuoka, Japan
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2018年 / 197卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1679
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [1] Evaluation and validation of the prognostic value of anti-MDA5 IgG subclasses in dermatomyositis-associated interstitial lung disease
    Xu, Yue-Tong
    Zhang, Ya-Mei
    Yang, Hong-Xia
    Ye, Li-Fang
    Chen, Fang
    Lu, Xin
    Wang, Guo-Chun
    Peng, Qing-Lin
    RHEUMATOLOGY, 2022, 62 (01) : 397 - 406
  • [2] EVALUATION AND VALIDATION OF THE PROGNOSTIC VALUE OF ANTI-MDA5 IGG SUBCLASSES IN DERMATOMYOSITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE
    Xu, Yue-Tong
    Zhang, Ya-Mei
    Yang, Hong-Xia
    Ye, Li-Fang
    Chen, Fang
    Lu, Xin
    Wang, Guo-Chun
    Peng, Qing-Lin
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2023, 41 (02) : 449 - 449
  • [3] Clinical Significance of Serum Chitotriosidase Level in Anti-MDA5 Antibody-positive Dermatomyositis-associated Interstitial Lung Disease
    Fujisawa, Tomoyuki
    Hozumi, Hironao
    Yasui, Hideki
    Suzuki, Yuzo
    Karayama, Masato
    Furuhashi, Kazuki
    Enomoto, Noriyuki
    Nakamura, Yutaro
    Inui, Naoki
    Suda, Takafumi
    JOURNAL OF RHEUMATOLOGY, 2019, 46 (08) : 935 - 942
  • [4] Assessment of anti-MDA5 antibody as a diagnostic biomarker in patients with dermatomyositis-associated interstitial lung disease or rapidly progressive interstitial lung disease
    Li, Liubing
    Wang, Qian
    Wen, Xiaoting
    Liu, Chenxi
    Wu, Chanyuan
    Yang, Funing
    Zeng, Xiaofeng
    Li, Yongzhe
    ONCOTARGET, 2017, 8 (44) : 76129 - 76140
  • [5] Evaluation of clinical prognostic factors for interstitial pneumonia in anti-MDA5 antibody-positive dermatomyositis patients
    Fujiki, Youhei
    Kotani, Takuya
    Isoda, Kentaro
    Ishida, Takaaki
    Shoda, Takeshi
    Yoshida, Shuzo
    Takeuchi, Tohru
    Makino, Shigeki
    MODERN RHEUMATOLOGY, 2018, 28 (01) : 133 - 140
  • [6] Clinical Features of Dermatomyositis/Polymyositis with Anti-MDA5 Antibody Positivity
    Chen, Qiuhe
    Qian, Long
    CONTRAST MEDIA & MOLECULAR IMAGING, 2022, 2022
  • [7] Prognostic Significance of Macrophage-Mannose Receptor, CD206, in Anti-MDA5 Antibody-Positive Dermatomyositis-Associated Interstitial Lung Disease
    Suzuki, Y.
    Fujisawa, T.
    Hozumi, H.
    Yasui, H.
    Karayama, M.
    Furuhashi, K.
    Enomoto, N.
    Nakamura, Y.
    Inui, N.
    Suda, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [8] Clinical, radiological and pathological features of anti-MDA5 antibody-associated interstitial lung disease
    Chen, Xixia
    Jiang, Wei
    Jin, Qiwen
    Peng, Qinglin
    Zhang, Lu
    Lin, Sang
    Lu, Xin
    Liu, Min
    Wang, Yuli
    Song, Aiping
    Feng, Ruie
    Wang, Guochun
    RMD OPEN, 2023, 9 (02):
  • [9] ANTI-MDA5 (+) CLINICALLY AMYOPATHIC DERMATOMYOSITIS-ASSOCIATED RAPIDLY PROGRESSIVE INTERSTITIAL LUNG DISEASE: ROLE OF HEMOPERFUSION WITH POLYMYXIN
    Selva-O'callaghan, A.
    Vizcaino, C.
    Ruiz-Rodriguez, J. C.
    Trallero-Araguas, E.
    Ramos, N.
    Berastegui, C.
    Gil Vila, A.
    Martinez, M. A.
    Solanich, X.
    Ferrer, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1095 - 1095
  • [10] Rituximab in the treatment of anti-MDA5 dermatomyositis-associated interstitial lung disease: a case-based literature review
    Nascimento, J.
    Tenazinha, C.
    Campanilho-Marques, R.
    Cordeiro, I
    Salgado, S.
    ARP RHEUMATOLOGY, 2022, 1 (02): : 168 - 173
12345